🏛️ Verified NIH Record • Updated 2026-08-05
Clevidipine for the Antihypertensive Treatment of Acute Intracerebral Hemorrhage (NCT06402968)
🟢 Recruiting Interventional Protocol 📊 Observational Clinical Research Sponsor: Zeenat Qureshi Stroke Institute
🩺 Plain-English Summary (8th-Grade Level)
The aim is to compare the rate of hypertensive subjects with ICH who reach SBP target with stability within 60 minutes of enrollment, among patients treated with IV clevidipine with those treated with alternate IV antihypertensive regimen.
Who can join: Review the eligibility criteria below.
Location: University of California — Irvine, California
Age range: 18 Years to 100 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (20 Sites)
- University of California — Irvine, California
- Antelope Valley Medical Center — Lancaster, California
- Stanford Medical Center (Stanford Health Care) — Palo Alto, California
- Cleveland Clinic Martin North Hospital — Stuart, Florida
- University of South Florida — Tampa, Florida
- Cleveland Clinic Florida — Weston, Florida
- Augusta University-Neuroscience Center — Augusta, Georgia
- Wellstar Kennestone Regional Medical Center — Marietta, Georgia
- Community Hospital — Munster, Indiana
- Frederick Memorial Hospital — Frederick, Maryland
- University of Michigan Health-West — Wyoming, Michigan
- CentraCare - St. Cloud Hospital — Saint Cloud, Minnesota
- University of Missouri — Columbia, Missouri
- Albany Medical Center — Albany, New York
- Icahn School of Medicine at Mount Sinai — New York, New York
- Cleveland Clinic Akron General — Akron, Ohio
- Cleveland Clinic Foundation — Cleveland, Ohio
- ProMedica Toledo Hospital — Toledo, Ohio
- UT Southwestern Medical Center — Dallas, Texas
- University of Texas Health Science Center San Antonio — San Antonio, Texas
📞 Contact the Study Coordinator
Phone: (949) 824-5011
Email: pashmeen.lakhani@zqsi.org
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Intracerebral Hemorrhage
- ROSE-Longitudinal Assessment With Neuroimaging — Chicago, Illinois
- Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial — Birmingham, Alabama
- Regulating Blood Pressure During Recovery From Intracerebral Hemorrhage and Ischemic Stroke — New Haven, Connecticut
- Biomarker and Edema Attenuation in IntraCerebral Hemorrhage (BEACH) — Birmingham, Alabama
- Synergistic Minimally Invasive Surgery and Deferoxamine in ICH — Chicago, Illinois
- Auricular VNS Following Intracerebral Hemorrhage — St Louis, Missouri
Explore by condition: All Intracerebral Hemorrhage clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.